Miracle Cure

by William Rosen

  Chandler, A. D. Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries. Cambridge, MA: Harvard University Press, 2005.

  Chicago Tribune. “Girl, 20, Dead After Refusal of Penicillin; Had 19 Transfusions for Blood Disease.” Chicago Tribune, August 26, 1943.

  Churchill, W. “We Shall Fight on the Beaches.” Great Speeches of the Twentieth Century. The Guardian, April 20, 2002.

  CIBA. Man and His Future: A CIBA Foundation Volume. Edited by Gordon Wolstenholme. Boston: Little, Brown, 1963.

  Clardy, J. F. “The Natural History of Antibiotics.” Current Biology 19, no. 11 (June 2009): 437–41.

  Clark, R. The Life of Ernst Chain: Penicillin and Beyond. London: Bloomsbury, 1985.

  Clarke, H. J. The Chemistry of Penicillin. Princeton, NJ: Princeton University Press, 1949.

  Coghill, R., et al. Method for Increased Yields of Pencillin. U.S. Patent No. 2423873 A, June 17, 1944.

  Colebrook, L. “Almroth Edward Wright: 1861–1947.” Obituary Notices of Fellows of the Royal Society 6, no. 17 (November 1948): 297–314.

  Colebrook, L. “Gerhard Domagk.” Biographical Memoirs of Fellows of the Royal Society 10 (November 1964): 39.

  Comas, I., et al. “Out-of-Africa Migration and Neolithic Co-Expansion of Mycobacterium tuberculosis with Modern Humans. Nature: Genetics 45, no. 10 (October 2013): 1176–82.

  Committee on Statistics. Steel Statistical Yearbook. Brussels: International Iron & Steel Institute, 1981.

  Congressional Quarterly. “Subcommittee Investigates Drug Prices.” CQ Almanac 1960, 16th ed. Washington, DC: Congressional Quarterly, 1960, 11-743–49.

  Cope, O. M. “The Treatment of the Surface Burns.” Annals of Surgery 117, no. 6 (June 1943): 885–93.

  Council on Drugs. “Blood Dyscrasias Associated with Chloramphenicol (Chloromycetin) Therapy.” Journal of the American Medical Association 172, no. 18 (April 30, 1960): 2044–45.

  Crivellato, E., et al. “Paul Ehrlich’s Doctoral Thesis: A Milestone in the Study of Mast Cells.” British Journal of Hematology 123 (2003): 19–21.

  Daemmrich, A. Pharmacopolitics: Drug Regulation in the United States and Germany. Philadelphia: Chemical Heritage Foundation, 2004.

  Daniel, T. M. Pioneers in Medicine and Their Impact on Tuberculosis. Rochester, NY: University of Rochester Press, 2001.

  Dauer, C., et al. “Mortality from Influenza, 1957–1958 and 1959–1960.” American Review of Respiratory Diseases 83 (1961): 15–28.

  Davies, J. “Antibiotic Resistance and the Future of Antibiotics.” In D. A. Relman, Microbial Evolution and Co-Adaptation: A Tribute to the Life and Scientific Legacies of Joshua Lederberg. Washington, DC: National Academies Press, 2009, 158–92.

  de Costa, C., et al. “American Resurrection and the 1788 New York Doctors’ Riot.” Lancet 377, no. 9762 (January 2011): 22–28.

  Dever, L. A. “Mechanisms of Bacterial Resistance to Antibiotics.” Archives of Internal Medicine 151, no. 5 (May 1991): 886–95.

  DiMasi, J. H. “The Price of Innovation: New Estimates of Drug Development Costs.” Journal of Health Economics 22, no. 2 (March 2003): 151–85.

  Dodson, G. “Dorothy Mary Crowfoot Hodgkin, O.M., 23 May 1910–29 July 1994.” Biographical Memoirs of the Fellows of the Royal Society 48 (December 1, 2002): 179–219.

  Doll, R. “Austin Bradford Hill, 8 July 1897–18 April 1991.” Biographical Memoirs of the Fellows of the Royal Society 40 (November 1994): 128–40.

  Douglas, S. “Georges Dreyer: 1873–1934.” Obituary Notices of Fellows of the Royal Society 1, no. 4 (December 1935): 568–76.

  Duggar, B. “Aureomycin: A Product of the Continuing Search for New Antibiotics.” Annals of the New York Academy of Sciences 51 (November 1948): 177–81.

  Dunhill, M. The Plato of Praed Street: The Life and Times of Almroth Wright. London: RSM Press, 2000.

  Ellis, J. J. His Excellency, George Washington. New York: Vintage, 2005.

  Federal Trade Commission. Federal Trade Commission Economic Report on Antibiotics Manufacture. Washington, DC: U.S. Government Printing Office, 1958.

  Ferry, G. Dorothy Hodgkin: A Life. London: Granta Books, 1998.

  Finland, M. J. “Occurrence of Serious Bacterial Infections Since Introduction of Antibacterial Agents.” Journal of the American Medical Association 170, no. 18 (August 1959): 2188–97.

  Finlay, M. R. “The Industrial Utilization of Farm Products and By-Products: The USDA Regional Research Laboratories.” Agricultural History 64, no. 2 (Spring 1990): 41–52.

  Finney, J. “Senate Panel Cites Mark-Ups on Drugs Ranging to 7,079%.” New York Times, December 8, 1959, 1.

  Fisher, M. W. “The Susceptibility of Staphylococci to Chloramphenicol.” Archives of Internal Medicine 105, no. 3 (March 1960): 412–23.

  Fisher, R. The Genetical Theory of Natural Selection. Oxford: Clarendon Press, 1930.

  Fitzgerald, J. “Louis Pasteur: His Contribution to Anthrax Vaccination and the Evolution of a Principle of Active Immunization.” California State Journal of Medicine 21, no. 3 (March 1923): 101–3.

  Flavell-White, C. “Pfizer’s Penicillin Pioneers.” TCE Today (February 2010): 54–55.

  Fleming, A. “Some Notes on the Bacteriology of Gas Gangrene.” Lancet 186, no. 4799 (August 1915): 376–78.

  Fleming, A. “On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to Their Use in the Isolation of B. influenzae. The British Journal of Experimental Pathology 10 (May 1929): 226–36.

  Fleming, A. “Penicillin.” Nobel Lecture. December 11, 1945. NobelPrize.org. Retrieved November 1, 2014. www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf.

  Florey, H. Interview by H. de Berg. Tape recording. April 16, 1967. National Library, Canberra.

  Folkers, K. A. Interview with Karl August Folkers. By L. Gortler. July 6, 1990. Philadelphia: Chemical Heritage Society.

  Forman, S. The Life and Writings of Thomas Jefferson, Including All of His Important Utterances on Public Questions, Compiled from State Papers and His Private Correspondence. Indianapolis: Bobbs-Merrill Company, 1900.

  Frith, J. “Syphilis: Its Early History and Treatment until Penicillin and the Debate on Its Origins.” Journal of Military and Veteran’s Health 20, no. 4 (2012).

  Galdston, I. Behind the Sulfa Drugs: A Short History of Chemotherapy. New York: Appleton-Century, 1943.

  Gaskins, H., et al. “Antibiotics as Growth Promotants: Mode of Action.” Animal Biotechnology 13, no. 1 (2002): 29–42.

  Geison, G. L. The Private Science of Louis Pasteur. Princeton, NJ: Princeton University Press, 1995.

  Godlee, S. R. Lord Lister. London: Macmillan, 1918.

  Gortler, L. “Merck in America: The First 70 Years from Fine Chemicals to Pharmaceutical Giant.” Bulletin for the History of Chemistry 25, no. 1 (2000): 1–9.

  Gradmann, C. “Robert Koch and the Pressures of Scientific Research: Tuberculosis and Tuberculin.” Medical History 45 (2001): 1–32.

  Graham, J. P. “Growth Promoting Antibiotics in Food Animal Production: An Economic Analysis.” Public Health Reports 122, no. 1 (January–February 2007): 79–87.

  Grayson, M. B. “Henry Welch, FDA, and the Origins of ICAAC.” Microbe 5, no. 9 (September 2010): 382.

  Greene, J. A. “Reform, Regulation, and Pharmaceuticals—The Kefauver-Harris Amendments at 50.” New England Journal of Medicine 167 (October 18, 2012): 1481–83.

  Greenwood, D. Antimicrobial Drugs: Chronicle of a Twentieth Century Medical Triumph. New York: Oxford University Press, 2008.

  Grinnell. “Doctors Get a Heap of Comfort from Grinnell Gloves.” Advertisement. Journal of the American Medical Association 63 (October–November 1914): 31.

  Grizzard, F. E. George Washington: A Biographical Companion. Santa Barbara, C
A: ABC-CLIO, 2002.

  Hager, T. The Demon Under the Microscope: From Battlefield Hospitals to Nazi Labs, One Doctor’s Heroic Search for the World’s First Miracle Drug. New York: Harmony Books, 2006.

  Hayes, J. “Notes on Forensic Medicine: Smell.” The Graveyard Shift (2008). Retrieved January 22, 2013. www.leelofland.com/wordpress/jonathan-hayes-notes-on-forensic-medicine-smell/.

  Hayes, P. “Carl Bosch and Carl Krauch: Chemistry and the Political Economy of Germany 1025–1945.” The Journal of Economic History 47, no. 2 (June 1987): 353–63.

  Heaman, E. St. Mary’s: The History of a London Teaching Hospital. London: Longmans, 2004.

  Heatley, N. B. “A New Type of Microrespirometer.” Journal of Biochemistry 33, no. 1 (January 1939): 53–67.

  Hebert, M. “Who Killed George Washington?” Medical Gumbo (February 16, 2009). Retrieved August 17, 2014. open.salon.com/blog/michael_hebert/2009/02/16/what_killed_george_washington.

  Hobby, G. Penicillin: Meeting the Challenge. New Haven, CT: Yale University Press, 1985.

  Hoeffle, M. L. “The Early History of Parke-Davis and Company.” Bulletin of the History of Chemistry 25, no. 1 (2000): 25–32.

  Holmberg, A., et al. “Les Prix Nobel en 1945.” Stockholm: The Nobel Foundation, 1946.

  Holmes, O. W. “On the Contagiousness of Puerperal Fever.” New England Quarterly Journal of Medicine 1 (1843): 503–30.

  Holmes, O. W. The Writings of Oliver Wendell Holmes, Vol. 9. Boston: Houghton Mifflin, 1899.

  Houting, B. A. “Did George Washington’s Doctors Hasten His Death?” Constitution Daily, August 30, 2011.

  Hughes, H. W. Alexander Fleming and Penicillin. London: Priory Press, 1979.

  Jacobs, W. A. (1924). “Certain Aspects of the Chemotherapy of Protozoan and Bacterial Infections.” Medicine 3, no. 2 (1924): 165–93.

  Janik, E. Marketplace of the Marvelous: The Strange Origins of Modern Medicine. Boston: Beacon Press, 2014.

  Johnson, S. Where Good Ideas Come From: The Natural History of Innovation. New York: Riverhead Books, 2010.

  Jonas, G. The Circuit Riders: Rockefeller Money and the Rise of Modern Science. New York: W. W. Norton, 1989.

  Jones, D. S. “The Burden of Disease and the Changing Task of Medicine.” New England Journal of Medicine 366 (June 21, 2012): 2333–38.

  Jones, T. Detailing the Physician: Sales Promotion by Personal Contact with the Medical and Allied Professions. New York: Romaine Pierson, 1940.

  Jonsen, A. R. The Birth of Bioethics. Oxford: Oxford University Press, 1998.

  Jordan, D. P. Napoleon and the Revolution. New York: Palgrave Macmillan, 2012.

  Jukes, T. H. “Some Historical Notes on Chlortetracycline.” Review of Infectious Diseases 7, no. 5 (September–October 1985): 702–7.

  Junod, S. W. “FDA and Clinical Drug Trials: A Short History.” Overviews of FDA History (September 7, 2014). Retrieved July 4, 2015. www.fda.gov/AboutFDA/WhatWeDo/History/Overviews/ucm304485.htm.

  Kahn, E. J. All in a Century: The First Hundred Years of the Eli Lilly Company. Indianapolis: Eli Lilly, 1976.

  Kandel, E. The Age of Insight: The Quest to Understand the Unconscious in Art, Mind, and Brain, from Vienna 1900 to the Present. New York: Random House, 2012.

  Kardas, P. “Noncompliance in Current Antibiotic Practice.” Infectious Diseases in Clinical Practice 14, no. 4 (July 2006): s11–s14.

  Keegan, J. The First World War. New York: Knopf, 1998.

  Kinch, M., et al. “An Analysis of FDA-Approved Drugs for Infectious Disease: Antibacterial Agents.” Drug Discovery Today 19, no. 9 (September 2014): 1283–87.

  Koch, R. Essays of Robert Koch. Edited by K. C. Carter. New York: Greenwood Press, 1987.

  Kogan, H. The Long White Line: The Story of Abbott Laboratories. New York: Random House, 1963.

  Kuehn, B. M. “Frances Kelsey Honored for FDA Legacy.” Journal of the American Medical Association 304, no. 19 (November 17, 2010): 2109–12.

  Laurence, W. L. “‘Wonder Drug’ Aureomycin Found to Spur Growth 50%.” New York Times, April 10, 1950, 1.

  Lawrence, C. “Joseph Lister.” In Oxford Dictionary of National Biography, edited by H. C. G. Matthew et al. Oxford: Oxford University Press, 2004.

  Lax, E. The Mold in Dr. Florey’s Coat. New York: Henry Holt, 2004.

  Le Fanu, J. The Rise and Fall of Modern Medicine. New York: Little, Brown, 1999.

  Lear, J. “Taking the Miracle Out of the Miracle Drugs.” Saturday Review, January 3, 1959, 35–41.

  Lear, J. “The Certification of Antibiotics.” Saturday Review, February 7, 1959, 43–48.

  Lear, J. “SR Drug Reports and the United States Senate.” Saturday Review, December 12, 1959, 49–50.

  Lear, J. “Public Health at 7 1/2 Per Cent.” Saturday Review, June 4, 1960, 37–41.

  Lehmann, J. “Para-Aminosalicylic Acid in the Treatment of Tuberculosis.” Lancet 247, no. 6384 (January 1946): 15–16.

  Light, D., et al. “Demythologizing the High Costs of Pharmaceutical Research.” BioSocieties 6 (February 2011): 34–50.

  Lister, J. “Antiseptic Principle in the Practice of Surgery.” British Medical Journal 2, no. 5543 (April 1967): 9–12.

  Lloyd, N. C. “Salvarsan—The First Chemotherapeutic Compound.” Chemistry in New Zealand 69, no. 1 (2005): 24–27.

  Loyd, E. “Aplastic Anemia Due to Chloramphenicol.” Antibiotics and Chemotherapy 2, no. 1 (January 1952): 1–4.

  Macfarlane, G. Howard Florey: The Making of a Great Scientist. Oxford: Oxford University Press, 1979.

  Macfarlane, G. Alexander Fleming: The Man and the Myth. Cambridge, MA: Harvard University Press, 1984.

  Macfarlane, G. “Howard Florey.” In Oxford Dictionary of National Biography, edited by H. C. G. Matthew et al. Oxford: Oxford University Press, 2004.

  Maddison, A. The World Economy. Paris: Development Centre of the Organisation for Economic Co-operation and Development, 2006.

  Madison, J. A. Eli Lilly: A Life, 1885–1997. Indianapolis: Indianapolis Historical Society, 1989.

  Maeder, T. Adverse Reactions. New York: William Morrow, 1994.

  Mahoney, T. The Merchants of Life: An Account of the American Pharmaceutical Industry. New York: Harper & Brothers, 1958.

  Maine Academy of Medicine and Science. “Therapeutics of a Country Doctor.” Journal of Medicine and Science 4, no. 1 (December 1897): 284.

  Major, R. T. “Selman Waksman—Scientist, Teacher, and Benefactor of Mankind.” Presentation Address for 1949 Research Award by the American Pharmaceutical Manufacturer’s Association, in Honor of Dr. Selman A. Waksman. June 9, 1949. Hot Springs, VA.

  Margulis, L., et al. What Is Life. New York: Simon & Schuster, 1995.

  Marks, H. M. “Making Risks Visible: The Science and Politics of Adverse Drug Reactions. In Ways of Regulating Drugs in the 19th and 20th Centuries, edited by J. P. Gaudilliere et al. Houndsmills, Basingstoke, UK: Palgrave Macmillan, 2012, 97–121.

  Maurois, A. The Life of Alexander Fleming: Discoverer of Penicillin. London: Jonathan Cape, 1959.

  Mayo Clinic. “Mayo Clinic Information: History” (2001–2015). Mayo Clinic. Retrieved March 17, 2015. www.mayoclinic.org/careerawareness/mi-history.html.

  McEvilla, J. D. Competition in the American Pharmaceutical Industry. Pittsburgh: University of Pittsburgh, 1955.

  McFadyen, R. “Thalidomide in America: A Brush with Tragedy. Clio Medica 11, no. 2 (July 1976): 79–93.

  McKelvey, M. Evolutionary Innovations: The Business of Biotechnology. New York: Oxford University Press, 1996.

  McLaren, A. Impotence: A Cultural History. Chicago: University of Chicago Press, 2007.

  Merck, G. W. “The Chemical Industry and Medicine.” Industrial and Engineering Chemistry 27, no. 7 (July 1, 1935): 739–41.

  Merck, G. W. “Biological Warfare: Report to the Secreta
ry of War by Mr. George W. Merck, Special Consultant for Biological Warfare” (January 3, 1946). Washington, DC: War Department Bureau of Public Relations, 1946.

  Meynell, E. “Some Account of the British Military Hospitals of World War I at Etaples, in the Orbit of Sir Almroth Wright.” Journal of the Army Medical Corps 142 (1996): 43–47.

  Miller, G. H. “Abrupt Onset of the Little Ice Age Triggered by Volcanism and Sustained by Sea-Ice/Ocean Feedbacks.” Geophysical Research Letters 39 (January 31, 2012).

  Miller, T. S. “Byzantine Hospitals.” Dumbarton Oaks Papers 38 (1984).

  Mintz, M. “‘Heroine’ of FDA Keeps Bad Drug Off Market.” Washington Post, July 15, 1962, 1.

  Moberg, C. L. “Penicillin’s Forgotten Man: Norman Heatley.” Science 253, no. 5021 (August 19, 1991): 734–35.

  Moskowitz, M. “Wonder Profits in Wonder Drugs.” The Nation, April 27, 1957, 357–60.

  MRC. “Treatment of Pulmonary Tuberculosis with PAS and Streptomycin: A Preliminary Report.” British Medical Journal (December 31, 1949): 1521.

  National Academies. “Articles of Organization of the National Research Council” (June 15, 2007). National Academies. Retrieved June 4, 2015. www.nationalacademies.org/nrc/na_070358.html.

  Nelson, K. E. “Early History of Infectious Disease.” In K. E. Nelson, Infectious Disease Epidemiology, 3rd ed. Burlington, MA: Jones and Bartlett, 2014, 1–21.

  Neushul, P. “Science, Government, and the Mass Production of Penicillin.” Journal of the History of Medicine and Allied Sciences 48, no. 4 (October 1993): 371–95.

  New Scientist. “Some Bacteria Choose to Live in a Pool of Penicillin.” New Scientist, June 8, 1972, 546.

  New York Times. “The New Hope for Tuberculosis: Discovery of ‘Opsonins’ Promises to Revolutionize Medicine.” New York Times, March 31, 1907, 1.

  New York Times. “Near End of Chase for Deadly Elixir: Government Agents Hope to Recover Today the Last of 700 Bottles.” New York Times, October 25, 1937.

  Nobel Prize Foundation. “The Nobel Prize in Chemistry 1965” (2014). NobelPrize.org. Retrieved April 30, 2015. www.nobelprize.org/nobel_prizes/chemistry/laureates/1965/.